Truist Financial Corp Sells 296,745 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

Truist Financial Corp reduced its stake in Teva Pharmaceutical Industries Ltd. by 30.5% in the fourth quarter, selling 296,745 shares and retaining 676,170 shares valued at $21.1 million. Other institutional investors like Horizon Investments LLC and Jennison Associates LLC also adjusted their positions, indicating varied sentiment towards the company. Teva Pharmaceutical Industries, a multinational pharmaceutical company focusing on generic medicines, has a “Moderate Buy” rating from analysts with a consensus target price of $41.78.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin